Labcorp Holdings, Inc. LH has announced the nationwide availability of the Lumipulse pTau-217/Beta Amyloid 42 Ratio — the first FDA-cleared blood-based in-vitro diagnostic (IVD) test to assist in ...

A new finger prick test claims to detect Alzheimer’s with 91% accuracy using p-tau217 biomarkers. Learn how this accessible ...

What if screening for the diseases that cause dementia could start with something as quick as a finger-prick blood test?

Diagnosing Alzheimer’s disease has long relied on expensive and invasive procedures, often delaying care until symptoms are well advanced. With the recent US Food and Drug Administration (FDA) ...

This transcript has been edited for clarity. Hi. I’m Art Caplan. I'm at the Division of Medical Ethics at NYU Grossman School of Medicine in New York City. The FDA recently cleared, for the first time ...

The U.S. Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other causes of cognitive decline, providing a broader understanding of when the ...

In an era with less political and cultural division — and less tech-driven diversion — the stunning advances in medicine seen in recent years would get far more attention. The rapid development of the ...

For decades, an Alzheimer’s diagnosis was a process of elimination — and often a late one, a Nature Medicine’s 2026 “Finger-Prick” study says. It wasn’t until memory faded and cognitive functions ...

A simple at-home brainwave test can detect signs of memory impairment linked to Alzheimer's disease years before clinical diagnosis is typically possible. This feat has been demonstrated by ...